Navigation Links
Sunflowers Could Hold the Key to New Class of AIDS Drugs

Scientists at the University of Bonn in Germany have come up with what could be a potential AIDS drug. They have found that a substance present in sunflowers prevents // the AIDS virus from replicating in cell cultures. It is not yet known if this would also apply to the actual disease.

The substance called as 'DCQA' has been the sole hope of producing a new class of AIDS drugs. But this is available in very minute quantities and naturally is pretty costly. The researchers from Bonn worked in collaboration with the Caesar research centre to make this substance available at a fraction of the earlier costs. The attempt to find the substance in sunflowers started with a mould called sclerotinia sclerotiorum. It was found that some varieties of sunflower were resistant to a disease called "white stem rot' that destroys the crops. Agricultural engineer Claudio Cerboncini proceeded to isolate the substance that confers protection on the sunflowers that are resistant to this fungal disease. The substance was dicaffeoyl quinic acid, or DCQA. "Dicaffeoyl quinic acid can prevent the HI virus from reproducing, at least in cell cultures," said Claudio Cerboncini.

"It is one of the few substances known today which inhibit viral integrase - this is an enzyme which is essential if the pathogen is to reproduce." Preliminary clinical tests have now borne out the hope that DCQA could herald in a new class of AIDS drugs. Dr. Esther Vogt of the Immunological Out-Patient Service of Bonn University Clinic, said, "We need these substances to expand our arsenal of effective weapons against the disease. It remains to be seen, however, whether they will prove to be as effective in clinical practice as they seem to be at present." The University of Bonn researchers have teamed up with Jülich Research Centre to see if they can manufacture this substance on a large scale.

Dr. Ralf Theisen
University of Bonn


Related medicine news :

1. Oleic-acid-rich Sunflowers Give Trans-fat Alternative - Study
2. Lean Protein Could Be Key to Obesity Drugs
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Nasal Spray Could Take Drugs Directly to Brain
5. Oxygen Usage During Exercise Could Indicate Heart Problems
6. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
7. Anger Could Be Linked To Weight Gain
8. A Seizure Late In Life Could be A Stroke Warning
9. New Findings Could Reduce The Extent Of Spinal Cord Injuries
10. Could There Be A Link Between Famine and Breast Cancer ?
11. Bone Marrow Cells Could Yield A New Lease of Life
Post Your Comments:

(Date:11/25/2015)... ... , ... “While riding the bus, I saw a passenger in a wheelchair ... to be a convenient and comfortable way to protect them from bad weather, so ... safely travel during cold or inclement weather. In doing so, it ensures that the ...
(Date:11/25/2015)... ... 2015 , ... Privately owned Contract Development and Manufacturing Organization ... current state of the art research, development and manufacturing facility outside of Fort ... capacity as well as to support its clients’ growing research and development and ...
(Date:11/25/2015)... ... , ... Students and parents have something to be thankful for this Thanksgiving ... awards. California Casualty is proud to support the contest designed to utilize ... driving, the number one killer of young drivers. , Almost 1,000 entries of ...
(Date:11/24/2015)... ... , ... New patients who wish to seek treatment for missing teeth can ... her Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 ... Missing teeth can lead to a variety of complications if they are not replaced ...
(Date:11/24/2015)... , ... November 25, 2015 , ... ... and development solutions for drugs, biologics, consumer health and global clinical supply services, ... at the upcoming Clinical Trial Supply East Asia Conference, to be held at ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... and VANCOUVER, Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ... ) announced today that the first patient has been ... as a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... Canada.  --> the United States ... the Phase 1/2 clinical trial, ESSA intends to demonstrate ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... new market research report "Spine Biologics Market by Product Type ... Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), ... by MarketsandMarkets, the global market was valued at $1.90 Billion ... 2020, at a CAGR of 4.4% during the forecast period ...
(Date:11/24/2015)... India , November 24, 2015 ... . --> adds Latest Guidebook ... report of 217 pages published in November 2015 ... its online business intelligence library at ... one of the fastest growing global economies with ...
Breaking Medicine Technology: